Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-labeled, Multicenter, Non-interventional Prospective PRO/QoL Registry for Patients With Osteoprotective Treatment for Bone Metastases of Breast or Prostate Cancer

NCT02410044 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT02410044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02410044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-labeled, Multicenter, Non-interventional Prospective PRO/QoL Registry for Patients With Osteoprotective Treatment for Bone Metastases of Breast or Prostate Cancer
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Completed
Start date
December 23, 2014
Completion date
August 16, 2020
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, breast cancer, prostate cancer